Abstract
Introduction: Dengue fever and dengue hemorrhagic fever (1) are usually a benign condition caused by an arthropod borne virus and bleeding is one of the dreaded complications associated with higher mortality in DHF/DSS (1) Dysfunction of platelets are Prothrombotic complications associated with severe cases of dengue. Thus, platelets could be considered cells that are active against the anti DENV immune response. Platelet transfusion is given in those patients who are either bleeding or having other hemorrhagic symptoms along with thrombocytopenia. AProspective study was conducted of 100 dengue positive patients with bleeding tendency in department of pathology, Government medical college and Sir. T. Hospital, Bhavnagar, Gujarat during period of July 2020 to MAY 2021.The patient who received multiple platelet transfusions showed post transfusion platelet increment of >0.5x105/mm3 from each unit
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call